A normally hard-headed bench just endorsed President Biden’s scheme to dictate how much drugmakers can charge under Medicare.

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

Trump demands U.S. drug prices match lowest international rates for some or face executive action. This article originally ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

Federal judges in Texas and Connecticut on Thursday ruled against arguments challenging the constitutionality of the Medicare ...

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

The Trump administration is launching a pressure campaign against prescription drugmakers in an effort to get them to lower ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Trump’s first-term rule—“Most Favored Nation”—was focused on lowering the cost of Medicare payments on certain drugs, but the ...

Earlier this year, President Trump issued an executive order pledging “immediate steps to end global freeloading” and ...

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

Over the past few weeks, major health insurers reported their mid-year earnings, and the results have been largely mixed.